A Quebec company has received the first kosher certification granted to medical marijuana products in Canada.
Tag Archives: Company
Weedmaps, one of the country’s larger and more established marijuana firms, is going all-in on Massachusetts and its new recreational pot market.
CBD—a purified weed extract that won’t get you stoned—is used to treat everything from breast cancer to stress relief, epilepsy to aching joints. VICE met up with David Bonvillain, who runs the CBD company Elite Botanicals, for an inside scoop on the extract’s “limitless future.”
High-level staff at outdoor recreational outfitter REI have internally discussed entering the marijuana industry, but amid ongoing uncertainty on the federal level, the company is not seriously considering such a move.
When it comes to edibles, ovens and crock pots cook cannabis pretty inconsistently, wasting weed and lowering the quality. With this in mind, entrepreneur Shanel Lindsay created her own science-savvy device that perfectly cooks pot every time you use it, leaving you ready to sprinkle it on your favorite foods in just one hour.
Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:SCQBD) (“Liberty” or the “Company”) announced today that there is no structural damage to its facility in Alachua, Florida as a result of Hurricane Irma.
Flow Kana is a cannabis distributor that promotes the sale of organic and sustainable marijuana. With recreational marijuana sales beginning next year in California, the company wants to help boost local farm-grown plants over commercial warehouse operations.
The first medical marijuana license issued by the state of Texas will be going to a company called Cansortium Texas. The company, with administrative offices in Schulenberg, Texas, says they are humbled and honored to have earned a license as a low-THC dispensing organization.
Almost three months after the initial public offering (IPO) of MedReleaf Corp. (TSX:LEAF), shares have yet to do much in either direction. The company, which came to market in what was then described as a “botched IPO,” fell quickly out of the gate from its IPO price.
Arizona’s attorney general is suing Insys Therapeutics over its marketing of the fentanyl opioid spray, Subsys, and that news caused the company’s shares to tumble 18.5% in August, according to S&P Global Market Intelligence.
Undoubtedly, a reversal in the federal government’s laxness on pot would be terrible news for marijuana stock investors, but not every last company would be decimated. One marijuana stock could still thrive, even with Jeff Sessions waving the metaphorical sword at the pot industry: Scotts Miracle-Gro.
“Complex Live” gets to know Artizen — a Seattle-based cannabis company that employs over a dozen military veterans — and its employees, many of whom have used the plant to treat PTSD.
Whereas most weed businesses are working harder than ever to increase their grow capacity, Cronos Group is a company that’s trying to work smarter. Based in Canada, Cronos Group is an investment firm that primarily invests in Canadian-based pot companies involved in Canada’s medical-marijuana industry.
Two banking pioneers during Russia’s chaotic lurch toward capitalism a quarter century ago think they’ve finally found another emerging market that can give them the same buzz.
In this Cal Can Biz Expo interview, watch Kristen Fox, Editor-in-Chief of MJINews.com and Marijuana Industry News magazine, interview A.J. Gentile, CEO of Speedweed.
KPIX 5’s Susie Steimle explains how one California company is changing the way pot dispensaries are keeping their product fresh.
GW Pharmaceuticals Plc. is a biopharmaceutical company that discovers, develops, and commercializes cannabinoid prescription medicines. Since May 10, 2013, the stock price has climbed 1,033%.
Australian drug regulators have granted what is believed to be the first licence to manufacture and supply medical cannabis in Western Australia.
When GW Pharmaceuticals announced its fiscal third-quarter results on Monday, the company provided plenty of information about its performance during the quarter. However, it wasn’t any of the numbers in the update that caused this decline. Instead, one word caused investors’ disappointment.
If just a single clinical trial works in favor of Cara Therapeutics, it could regain everything it’s recently lost and possibly hit a $1 billion market cap.
American Green Inc., a maker of cannabis products, is taking an unusual step to attract new customers as it capitalizes on California legalizing marijuana: It’s buying an entire town.
In mid-June home lawn and fertilizer care specialist The Scotts Miracle-Gro Company (NYSE:SMG) lowered its full-year fiscal 2017 outlook, citing a more than 10% drop in mass retail sales compared to the year-to-date checkpoint from the previous year. That was caused by challenging weather this spring in core markets across the United States.
The Creso Pharma Ltd (ASX: CPH) share price has been amongst the biggest movers on the market this morning. This morning the company revealed that it plans to expand into the Canadian market.
In this Cal Can Biz Expo interview, watch Kristen Fox, Editor-in-Chief of MJINews.com and Marijuana Industry News magazine, interview Sturges Karban, CEO of MJIC.
The Canadian government is moving quickly to legalize marijuana and, unlike the patchwork state-by-state approach unfolding in the U.S., Canada is set to make it legal nationwide by this time next year.
There are three different general types of marijuana stocks on the market. Some are marijuana growers. Others provide supplies to marijuana growers. Then there’s the third type: the biotechs. Zynerba Pharmaceuticals belongs to the last kind of marijuana stock.
Only 51 authorized licenses have been given to suppliers of medical marijuana in Canada. Canopy Growth Corporation holds four of them.
On June 27, Cara Therapeutics (NASDAQ:CARA), a clinical-stage biotech company with a focus on treating chronic pain and pruritus, surged to an all-time intraday high of $28.50 a share. Cara was just $73 million away from joining the $1 billon market cap ranks.
The results for Canopy Growth’s stock have been terrific so far, yielding a return of over 152% since inception. The stock has been performing well despite lacklustre results and frequent losses.
Organa Brands is setting itself up to be the best and biggest nation-wide cannabis company. This multi-brand company posts top line sales of over $100 million.
The Auscann Group Holdings Ltd share price has continued its strong run and is up a further 6% to 46 cents today. Why has it jumped? Let’s look to find out.
MedReleaf is one of less than four dozen licensed producers and retailers of medical cannabis products in Canada. The company was founded just four years ago, and it focuses on supplying dried cannabis, cannabis oils, and cannabis oil capsules to qualified medical patients in Canada.
If these headsets make ordering marijuana easier, which would in turn increase sales, this technology will be another boon for marijuana dispensary stocks.
Aurora Cannabis Inc. today is one of the pre-eminent marijuana producers listed on the TSX Venture Exchange with a market capitalization just shy of $750 million, making it the fourth-largest marijuana stock behind only GW Pharmaceuticals PLC- ADR, Canopy Growth Corp., and Aphria Inc.
Unlike GW Pharmaceuticals and Zynerba Pharmaceuticals, which rely on cannabinoid-based medicines to fill out the entirety of their drug-development pipelines, Arena Pharmaceuticals is one of the drug developers that have some of their pipelines devoted to cannabinoid-type therapeutics or CB agonists and other portions devoted to non-cannabinoid medicines.
Warren Buffett is well known as the most successful investor of all time. Buffett spent his formative years under the tutelage of Benjamin Graham, who is known today as the “father of value investing.” Let’s see whether or not Aphria Inc. can pass Buffett’s mentor’s criteriea test.
As California’s medical marijuana industry has grown to an $800 million dollar business, one company is hoping to take advantage of that by delivery the product directly to the customer.
Shares of Cara Therapeutics Inc., a clinical-stage biotech company with a focus on treating pain and pruritus, rocketed higher by as much as 11% during Wednesday’s trading session after providing an update to its phase 3 trial involving kappa opioid receptor agonist CR845.
Though there are a number of direct players in the industry, some of the most surprising growth can be seen in emerging industry players. One such name is Scotts Miracle-Gro.
On July 1, 2017, Nevada will legalize the use and sale of recreational marijuana, which could be a catalyst for long-term gains for three cannabis stocks.
The industry and the Canopy Growth Corp. were going to be the next big thing for investors, but things have cooled down gradually over the past few months.
Here is a novel concept could increase the safety of cannabis deliveries and be a boon for marijuana stocks: drone deliveries. Not only will drone deliveries increase safety, but they will also make delivery faster and more convenient.
MedReleaf Corp. is the latest cannabis stock to hit the TSX. Could they be the spark to reignite the second wave of the green rush?
Multi-state cannabis company iAnthus Capital Management has now planted its flag in New York with Monday’s announced acquisition of Valley Agriceuticals.
The threat of increasing competition for GW Pharmaceuticals’ promising epilepsy drug took a toll on investors’ confidence last month.
Oh, how the mighty have fallen. Shares of Canopy Growth Corp. have dropped by over $6 a share, or 47.5%, since the middle of February.
In the red-hot world of marijuana stocks, there can be no question that GW Pharmaceuticals reigns supreme, but could small-cap biotech Zogenix be a threat?
If there is a “Holy Grail” milestone out there for cannabis stocks, it’s the $1 billion sales mark. The first cannabis company to hit $1 billion in sales will likely validate the industry to Wall Street and investors. But which marijuana stock has the best chance at being first to $1 billion in annual sales?
How about another cannabis company to spark up your interest? Newstrike Ltd. is Canada’s newest pot stock that will be hitting the TSX Venture Exchange this Thursday.
Canadian band, the Tragically Hip are hoping to get ahead by a few days, partnering with a Canadian medical marijuana company just before it’s set to go public.